Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
The United Kingdom Health Security Agency (UKHSA) is a system leader for health security; taking action internationally to strengthen global health security, providing trusted advice to government and the public and reducing inequalities in the way different communities experience and are impacted by infectious disease, environmental hazards, and other threats to health.
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
Maybe you need an ‘elevator pitch’ for investors. Or just a quick intro for customer meetings or networking. We all have reasons for explaining quickly what our firm is for. This webinar is an interactive workshop designed to help you communicate how you help your customers and what you do better than your competitors.
Stephen Tunnicliffe-Wilson is an exited Founder, Engineer, CTO and CEO. He has spent his career communicating complex subjects in simple terms. Steve has helped many companies improve their pitches to win investment and sell to customers.
This is the first event in a three-part event series which will help growing ventures understand and develop compliance foundations that investors expect.
Early-stage companies such as those in life-sciences operate in one of the most opportunity-rich—and heavily scrutinised—sectors in the UK. As they grow, seek investment, partner with strategic corporates, or prepare for acquisition, investors and financing banks will expect credible, proportionate governance foundations that protect and create value, and minimise avoidable risk.
The industry is increasingly focused on speeding up antibody validation and biopharmaceutical research and development. Efficient execution of these processes, along with effective management of regulatory milestones, has become a central concern across the field. Creative Biolabs has recently officially launched a full-process service portfolio covering "from discovery to production", providing biopharmaceutical companies with faster, more stable, and more scalable technical channels.
In a new guest blog post – Dr Owen Jones, winner of the Amsbio 2024 ISSCR Travel Grant, reflects on his work developing and applying human stem cell–derived retinal organoid models for disease research and therapeutic discovery. Amsbio is delighted to have played a supporting role in Dr Jones scientific endeavors.
Revolutionising Imaging: The Power and Promise of LAFOV PET and the NPIP Network
Webinar 1 | Introduction to Long Axial Field of View (LAFOV) PET: Capabilities and Transformational Potential
(12/01/26 4pm GMT)
Speakers:
Dr Simon R. Cherry, University of California, Davis, and King’s College London
Dr Antonis Kalemis, Siemens Healthineers
Stewart Young, United Imaging
The United Kingdom Health Security Agency (UKHSA) is a system leader for health security; taking action internationally to strengthen global health security, providing trusted advice to government and the public and reducing inequalities in the way different communities experience and are impacted by infectious disease, environmental hazards, and other threats to health.